Home Newsfeeds Copart Q4 EPS $1.13 Beats $1.10 Estimate

Copart Q4 EPS $1.13 Beats $1.10 Estimate

Copart (NASDAQ:CPRT) reported quarterly earnings of $1.13 per share which beat the analyst consensus estimate of $1.10 by 2.73 percent. This is a 9.71 percent increase over earnings of $1.03 per share from the same

byMichael Horton

September 7, 2022

1 minute read

News

CPSI Announces Strategic Partnership With i2i Population Health To Ease Complexity Of Quality Program Reporting And Help Improve Patient Outcomes

By Benzinga Newsdesk

September 20, 11:01 AM

Easy access to real-time data allows hospitals and providers to participate in alternative payment models (APM), receive added incentive payments and improve patient outcomes CPSI (NASDAQ:CPSI), a healthcare solutions

CPSI

Vertex Pharma’s Flagship Cystic Fibrosis Drug Scores FDA Approval For Infants

By Vandana Singh

September 2, 1:45 PM

The FDA has approved Vertex Pharmaceuticals Incorporated’s (NASDAQ:VRTX) Orkambi (lumacaftor/ivacaftor) for expanded use to include children with cystic fibrosis (CF) ages…

VRTX

Kevin O’Leary Says You Should Quit Your Job, Do This Instead: Elon Musk And Doge Co-Founder Disagree

By Chris Katje

March 5, 6:05 PM

Investor and Shark Tank star Kevin O’Leary is known for his thoughts and opinions on investing and being an entrepreneur. Sometimes his comments can be controversial and generate a strong buzz on social media. Here’s the latest business take from O’Leary.

WMT